Summary
In the isolated perfused rat pancreas various sulfonylurea drugs were tested with a basal glucose level of 1 mg/ml in the perfusion buffer and were found to cause a biphasic insulin response. NOVO CS 476, a new and potent sulfonylurea, and glibenclamide qualitatively differed from tolbutamide, glibornuride, glipizide, and glisoxepide, which were all alike in terms of the relationship between first and second phases of insulin release.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Artini, D., Abbiati, R., Orsini, G., Parenti, M. A., Bloch, K., Daturi, S., Mandelli, V.: Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide, Diabetologia 9 (Suppl.), 311–316 (1973)
Bennett, L. L., Curry, D. L., Curry, K.: Differences in insulin release in response to glucose and tolbutamide stimulation. Proc. Soc. exp. Biol. (N. Y.) 144, 436–439 (1973)
Bosboom, R. S., Zweens, J., Bouman, P. R.: Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreas. Diabetologia 9, 243–250 (1973)
Bowen, V., Lazarus, N. R.: Insulin release from the perfused rat pancreas. Mode of action of tolbutamide. Biochem. J. 142, 385–389 (1974)
Chen, R. F.: Removal of fatty acids from serum albumin by charcoal treatment. J. biol. Chem. 242, 173–181 (1967)
Curry, D. L.: Insulin secretory dynamics in response to slowrise and square-wave stimuli. Amer. J. Physiol. 221, 324–328 (1971)
Grodsky, G. M., Curry, D. L., Landahl, H., Bennett, L. L.: Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system. Acta diabet. lat. 6 (Suppl. 1), 554–579 (1969)
Grodsky, G. M., Lee, J., Fanska, R., Smith, D.: Insulin secretion from the in vitro perfused pancreas of the rat: Effect of Ro 6-4563 and other sulfonylureas. In: Recent hypoglycemic sulfonylureas, pp. 83–94. Bern: Hans Huber 1971
Haupt, E., Köberich, W., Beyer, J., Schöffling, K.: Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects. Diabetologia 7, 449–454 (1971)
Haupt, E., Köberich, W., Beyer, J., Schöffling, K.: Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. II. Repeated administration in combination with glucose. Diabetologia 7, 455–460 (1971)
Heding, L. G.: Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8, 260–266 (1972)
Hellman, B.: Potentiating effects of drugs on the binding of glibenclamide to pancreatic beta cells. Metabolism 23, 839–846 (1974)
Hellman, B.: Factors affecting the uptake of glibenclamide in microdissected pancreatic islets rich in β-cells. Pharmacology (Basel) 11, 257–267 (1974)
Hellman, B., Sehlin, J., Täljedal, I.-B.: The pancreatic β-cell recognition of insulin secretagogues. Islet uptake of sulfonylureas. Diabetologia 9, 210–216 (1973)
Joergensen, K. D.: The pharmacology of a new hypoglycaemic agent. N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N′-cyclohexylurea (NOVO CS 476). Acta pharmacol. (Kbh.), (in press 1976)
Laube, H., Fussgänger, R. D., Schröder, K. E., Pfeiffer, E. F.: Der Einfluß eines neuen Sulfonylharnstoffes auf die Insulinund Glucagonsekretion des isolierten perfundierten Pankreas. Arzneimittel-Forsch. 22, 2186–2188 (1972)
Lenzen, S.: The immediate insulin secretory response of the isolated rat pancreas to tolbutamide and glucose. FEBS Letters 49, 407–408 (1975)
Loubatieres, A., Mariani, M. M., Chapal, J.: Insulinosécrétion étudiée sur le pancréas isolé et perfusé du rat: I. Synergie entre glucose et sulfamides hypoglycémiants. Diabetologia 6, 457–466 (1970)
Loubatieres, A., Mariani, M. M., Ribes, G., Alric, R.: Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide). Acta diabet. lat. 10, 261–281 (1973)
Pfeiffer, E. F., Fussgänger, R., Hinz, M., Katsilambros, N., Laube, H.: Dynamics of insulin and glucagon secretion of the isolated perfused rat pancreas and islets following and in presence of newer sulfonylureas. In: Recent hypoglycemic sulfonylureas, pp. 97–113. Bern: Hans Huber 1971
Sehlin, J.: Evidence for specific binding of tolbutamide to the plasma membrane of the pancreatic β-cells. Acta diabet. lat. 10, 1052–1060 (1973)
Sussman, K. E., Vaughan, G. D., Timmer, R. F.: An in vitro method for studying insulin secretion in the perfused isolated rat pancreas. Metabolism 15, 466–476 (1966)
Tasaka, Y., Sekine, M., Sugimoto, C., Ohgawara, H., Shizume, K.: Effect of glipizide on the release of insulin in the perfused rat pancreas in vitro. Endocr. jap. 21, 279–281 (1974)
Täljedal, I.-B.: Uptake of glibornuride by microdissected pancreatic islets. Hormone Res. 5, 211–216 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gotfredsen, C.F. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas. Diabetologia 12, 339–342 (1976). https://doi.org/10.1007/BF00420977
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00420977